Effect of dexfenfluramine on the development of pulmonary hypertension in mice over-expressing the serotonin transporter Source: Eur Respir J 2005; 26: Suppl. 49, 352s Year: 2005
Pulmonary arterial hypertension phenotype in VIP knockout mice Source: Eur Respir J 2006; 28: Suppl. 50, 546s Year: 2006
Polymorphism of the serotonin transporter and 2a receptor gene in COPD with and without pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008
Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007
Endothelin-a receptor antagonists reduce eNOS gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 271s Year: 2003
Overexpression of serotonin receptor 1B (5HT-1B) responsible for overflow induced experimental pulmonary arterial hypertension development Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation Year: 2003
Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH) Source: Annual Congress 2006 - Cellular mechanisms of airway disease Year: 2006
Targeted adenoviral gene transfer of wild type (wt) BMPR2 attenuates hypoxic pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 238s Year: 2005
Hyperplasia of pulmonary artery smooth muscle cells in primary and secondary pulmonary hypertension is causally related to serotonin transporter overexpression Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002
TrkB expression is altered in hypoxia-induced pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 606s Year: 2007
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 20s Year: 2003
Blockage of serotonin receptors and transporter reduces bleomycin lung fibrosis in mice Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005
Serotonin transporter genes, pulmonary haemodynamics and pulmonary hypertension Source: Annual Congress 2005 - Scientific year in review Year: 2005
The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43 Source: International Congress 2017 – Experimental PH Year: 2017
Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012
Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016
The inhibition of MRP4, a new target in pulmonary hypertension (PH), prevents and reverses hypoxia-induced pH in mice Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009
Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006
Reduction in serotonin signaling via TPH1 inhibition attenuates the progression of PAH in mice with genetic ablation of endothelial BMPR-II Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012
Effect of eNOS gene overexpression on the vascular reactivity of isolated pulmonary arteries of chronic hypoxic rats Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease" Year: 2006